These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2582169)

  • 21. Evidence for multiple tachykinin receptor subtypes on the rabbit iris sphincter muscle.
    Too HP; Unger WG; Hanley MR
    Mol Pharmacol; 1988 Jan; 33(1):64-71. PubMed ID: 2892126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of substance P and related peptides on the guinea-pig lung strip.
    Webber SE; Foreman JC
    Agents Actions; 1984 Apr; 14(3-4):425-8. PubMed ID: 6203363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of potency of substance P and related peptides on [3H]-acetylcholine release, and contractile actions, in the guinea-pig ileum.
    Fosbraey P; Featherstone RL; Morton IK
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(2):111-5. PubMed ID: 6206402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation.
    Leander S; Håkanson R; Rosell S; Folkers K; Sundler F; Tornqvist K
    Nature; 1981 Dec; 294(5840):467-9. PubMed ID: 6171733
    [No Abstract]   [Full Text] [Related]  

  • 25. Tachykinin receptors mediating responses to sensory nerve stimulation and exogenous tachykinins and analogues in the rabbit isolated iris sphincter.
    Hall JM; Mitchell D; Morton IK
    Br J Pharmacol; 1993 Aug; 109(4):1008-13. PubMed ID: 8401912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effects of substance P, neurokinin A, physalaemin and eledoisin in facilitating a nociceptive reflex in the rat.
    Cridland RA; Henry JL
    Brain Res; 1986 Aug; 381(1):93-9. PubMed ID: 2428434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
    Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
    Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptors for substance P. II. Classification by agonist fragments and homologues.
    Regoli D; Mizrahi J; D'Orléans-Juste P; Escher E
    Eur J Pharmacol; 1984 Jan; 97(3-4):171-7. PubMed ID: 6200336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Classification of tachykinin receptors in muscularis mucosae of opossum oesophagus.
    Daniel EE; Cipris S; Manaka Y; Bowker P; Regoli D
    Br J Pharmacol; 1989 Aug; 97(4):1013-8. PubMed ID: 2477100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ontogeny of the antidipsogenic effect of eledoisin and physalaemin in the rat.
    De Caro G; Perfumi M; Epstein AN
    Appetite; 1987 Dec; 9(3):179-89. PubMed ID: 3435135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of receptors for two Xenopus gastrointestinal tachykinin peptides in their species of origin.
    Johansson A; Liu L; Holmgren S; Burcher E
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):35-45. PubMed ID: 15235762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacological profile of a substance P (SP) antagonist. Evidence for the existence of subpopulations of SP receptors.
    Rosell S; Björkroth U; Xu JC; Folkers K
    Acta Physiol Scand; 1983 Mar; 117(3):445-9. PubMed ID: 6192681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological characterization of four related substance P antagonists.
    Björkroth U; Rosell S; Xu JC; Folkers K
    Acta Physiol Scand; 1982 Oct; 116(2):167-73. PubMed ID: 6188324
    [No Abstract]   [Full Text] [Related]  

  • 34. A study of [D-Pro2, D-Phe7, D-Trp9]-substance P and [D-Trp7,9]-substance P as tachykinin partial agonists in the rat colon.
    Bailey SJ; Jordan CC
    Br J Pharmacol; 1984 Jun; 82(2):441-51. PubMed ID: 6203595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mechanism of peptidergic miosis. I. The structural basis of miotic potency among biologically active polypeptides.
    Bito LZ; Baroody RA; Backerman A
    Curr Eye Res; 1981-1982; 1(10):559-65. PubMed ID: 6178553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The actions of some vasoactive polypeptides and their antagonists on the anococcygeus muscle.
    Gillespie JS; McKnight AT
    Br J Pharmacol; 1978 Feb; 62(2):267-74. PubMed ID: 623939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of drinking but not feeding by central eledoisin and physalaemin in the rat.
    Massi M; Micossi LG; de Caro G; Epstein AN
    Appetite; 1986 Mar; 7(1):63-70. PubMed ID: 3963799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder.
    Burcher E; Buck SH; Lovenberg W; O'Donohue TL
    J Pharmacol Exp Ther; 1986 Mar; 236(3):819-31. PubMed ID: 2419545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tachykinins and bombesin excite non-pyramidal neurones in rat hippocampus.
    Dreifuss JJ; Raggenbass M
    J Physiol; 1986 Oct; 379():417-28. PubMed ID: 2435894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurokinin A-stimulated phosphoinositide breakdown in rabbit iris sphincter muscle.
    Taniguchi T; Ninomiya H; Fukunaga R; Ebii K; Yamamoto M; Fujiwara M
    Jpn J Pharmacol; 1992 Jun; 59(2):213-20. PubMed ID: 1279251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.